Respiratory symptoms and anaphylaxis were significantly more frequent in the case of IgE-AFR than in non-IgE-AFR (39.8 vs 6.7 and 36.4 vs 4.0, respectively). This evidence concerns the gene IGHE and anaphylaxis.